109 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
Revolution in the fight against autoimmune diseases: Granite Bio debuts with $100 million of capital

Breakthrough antibody therapies target the roots of inflammation and promise breakthroughs for millions of patients

30-Apr-2025

Granite Bio AG has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures. Granite’s pipeline features two first-in-class antibodies ...

more

image description
BioCopy accelerates the fight against cancer

Shorten research and development time for cancer drugs from 3 years to 12 months and significantly reduce development costs

24-Mar-2025

The German-Swiss biotechnology start-up BioCopy has secured new capital of 8 million euros. This sum is an important step for the company on its mission to produce more effective cancer drugs in the shortest possible time and at significantly lower costs. The company is supported by a group of ...

more

image description
Energy-efficient cooling thanks to ionic wind

Empa spin-off awarded

12-Feb-2025

Thanks to a new type of airflow booster for ionic wind, completely new fields of application are opening up for the start-up Ionic Wind Technologies. In future, the patented technology is to be used primarily for cooling data centers and high-performance electronics. The Empa spin-off has already ...

more

image description
Start-up boom thriving

In 2024, 37 new spin-offs were founded at ETH Zurich, a large proportion of them in the fields of AI and biotechnology.

04-Feb-2025

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research. Start-ups in the fields of artificial intelligence and biotechnology were particularly well represented. Artificial Intelligence and machine learning led the list with ten ...

more

image description
ETH Zurich researcher aims to prevent urinary tract infections with a vaccine

Her start-up Baxiva is developing a vaccine that makes bacteria visible to the immune system

03-Feb-2025

Every second woman and every eighth man suffer from urinary tract infections. These are painful and can recur with serious health consequences. Pioneer Fellow Giorgia Greter has a solution. Giorgia Greter could have been sitting in one of these minimalist, but elegant offices of a venture capital ...

more

image description
Oxyle receives 16 million US dollars to combat "perpetual chemicals" in our water

Revolutionary water treatment technology destroys over 99% of PFAS and changes the way industries deal with toxic water pollution

31-Jan-2025

Even as a child in Delhi, Fajer Mushtaq asked himself the same question every time he turned on the tap: Is this water safe to drink? Today, this question is more relevant than ever - not only in India, but worldwide. The reason for this is PFAS, so-called "perpetual chemicals", which are found ...

more

image description
Swiss startup Risklick launches AI-based software for medical device clinical trials

Protocol AI accelerates clinical trial development and patient access to medical device

27-Jan-2025

Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of its kind and marks a turning point in the medical device industry. It uses artificial intelligence to accelerate the development of clinical ...

more

image description
Araris Biotech announces research collaboration and option to license agreement with Chugai Pharmaceutical Co.

Araris to receive an upfront fee and milestone payments potentially totalling USD 780 million plus royalties on net product sales

15-Jan-2025

Araris Biotech AG, a Swiss oncology biotech spin-off company developing next-generation antibody drug conjugates (ADCs), announced they have entered a Research Collaboration and Option to License Agreement (“RCO”) under which Araris will use its proprietary linker-conjugation platform, AraLinQ™, ...

more

image description
For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin

“Our method, which involves equipping blood cells with a kind of protective shield and then targeting and removing diseased cells, smooths the way for treatments that could not have been used in that way before”

17-Dec-2024

Start-up Cimeio Therapeutics intends to pave the way for gentler and more efficient treatments for diseases such as blood cancer. The company, a spin-off of the University of Basel, has just concluded an important collaboration agreement: Cimeio is joining forces with the pharmaceutical firm ...

more

image description
A thinner thermal insulation for buildings

ETH spin-off Aeroskin Tech is developing innovative thermal insulation that uses aerogel technology to insulate buildings more efficiently and more sustainably

10-Dec-2024

When winter arrives and the temperature drops, we can either put on some warm clothing or turn up the heating and live with the additional costs. But what if the solution for a warm and energy-friendly home lies in the walls of the building? The more effectively buildings are thermally insulated ...

more

Page 1 From 11
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE